Novel FDG-PET findings in anti-NMDA receptor encephalitis: a case based report

Mohsin Maqbool1, Deanna A Oleske, A H M Huq

  • 1Department of Pediatrics and Neurology, Wayne State University School of Medicine, Detroit, Michigan, USA. drmohsinch@gmail.com

Insights

This case report details a 15-year-old boy with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. Novel fluorodeoxyglucose-positron emission tomography (FDG-PET) findings revealed cerebellar changes, offering new diagnostic insights.

Area of Science:

  • Neurology
  • Immunology
  • Nuclear Medicine

Background:

  • Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a severe autoimmune disorder affecting the central nervous system.
  • Clinical presentation can be diverse, including psychiatric symptoms, seizures, and movement disorders.
  • Standard neuroimaging like MRI may not reveal early or specific abnormalities.

Observation:

  • A previously healthy 15-year-old male presented with acute onset hallucinations, seizures, and rapid mental status decline.
  • Neurological examination revealed nonverbal status and oro-lingual-facial dyskinesias.
  • Initial extensive work-up and serial brain MRI scans were unremarkable.

Findings:

  • Fluorodeoxyglucose-positron emission tomography (FDG-PET) demonstrated initial global hypometabolism with a focal hypermetabolic lesion in the right cerebellar cortex.
  • Quantitative serology confirmed the diagnosis of anti-NMDAR encephalitis.
  • Following treatment with intravenous immunoglobulin, repeat FDG-PET showed overall improvement, with the right cerebellar cortex now exhibiting focal hypometabolism.

Implications:

  • This case highlights the utility of FDG-PET in diagnosing and monitoring anti-NMDAR encephalitis, particularly when MRI is normal.
  • The distinct cerebellar metabolic changes observed represent a novel imaging finding in this condition.
  • These findings may improve early detection and understanding of the pathophysiology of NMDAR encephalitis.

Related Concept Videos

Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.